Clinical trials
Lung Diseases trials in Brazil with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Unknown status | 4 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Federal University of Minas Gerais | 2 |
| Centro Universitário Augusto Motta | 1 |
| Centro Universitário de Anapolis | 1 |
| Federal University of Paraíba | 1 |
| Hospital Israelita Albert Einstein | 1 |
| Hospital Santa Marcelina | 1 |
| Hospital de Clinicas de Porto Alegre | 1 |
| Júnea Regina Pires Drews | 1 |
| Suellen Andrade | 1 |
| Universidade Federal de Sao Carlos | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases | 13 |
| Pulmonary Disease, Chronic Obstructive | 3 |
| Dyspnea | 2 |
| Respiratory Insufficiency | 2 |
| Anxiety Disorders | 1 |
| COVID-19 | 1 |
| Heart Diseases | 1 |
| Idiopathic Pulmonary Fibrosis | 1 |
| Lung Diseases, Interstitial | 1 |
| Lung Diseases, Obstructive | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.